Jeroen G. Noordzij

Jeroen G. Noordzij

Auto-generated profile, based on publicly available information

Jeroen G. Noordzij

Department of Paediatrics, Reinier de Graaf Gasthuis, Delft, The Netherlands

Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 October 2001 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
SMStephan Martin
Stephan Martin
DWDorothea Wolf-Eichbaum
Dorothea Wolf-Eichbaum
GDGaby Duinkerken
Gaby Duinkerken
WSWerner A. Scherbaum
Werner A. Scherbaum
HKHubert Kolb
Hubert Kolb
BRBart O. Roep
Bart O. Roep
Type 1 diabetes results from an immune-mediated destruction of pancreatic beta cells. The disease can be transmitted by bone marrow transplantation in humans1 and animals.2,3 Furthermore, T cells that are reactive to several islet autoantigens have been identified in both mice and humans.4,5 Although it is generally accepted that T cells have a role during the disease process, the possible role of B cells and autoantibodies in type 1 diabetes in humans has not been fully resolved. When they are activated, B cells can produce autoantibodies to pancreatic beta-cell antigens — such as glutamic acid decarboxylase 65 (GAD65), insulin, or the tyrosine phosphatase–like autoantigen IA-2 — and are able to take up and present autoantigen to T cells.6,7

15 March 2021 in European Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
MKMatthijs D. Kruizinga
Matthijs D. Kruizinga
DPDaphne Peeters
Daphne Peeters
MVMirjam van Veen
Mirjam van Veen
MHMarlies van Houten
Marlies van Houten
JWJantien Wieringa
Jantien Wieringa
GDGertjan J. A. Driessen
Gertjan J. A. Driessen
The coronavirus disease 2019 pandemic has enormous impact on society and healthcare. Countries imposed lockdowns, which were followed by a reduction in care utilization. The aims of this study were to quantify the effects of lockdown on pediatric care in the Netherlands, to elucidate the cause of the observed reduction in pediatric emergency department (ED) visits and hospital admissions, and to summarize the literature regarding the effects of lockdown on pediatric care worldwide. ED visits and hospital admission data of 8 general hospitals in the Netherlands between January 2016 and June 2020 were summarized per diagnosis group (communicable infections, noncommunicable infections, (probable) infection-related, and noninfectious). The effects of lockdown were quantified with a linear mixed effects model. A literature review regarding the effect of lockdowns on pediatric clinical care was performed. In total, 126,198 ED visits and 47,648 admissions were registered in the study period. The estimated reduction in general pediatric care was 59% and 56% for ED visits and admissions, respectively. The largest reduction was observed for communicable infections (ED visits: 76%; admissions: 77%), whereas the reduction in noninfectious diagnoses was smaller (ED visits 36%; admissions: 37%). Similar reductions were reported worldwide, with decreases of 30–89% for ED visits and 19–73% for admissions.Conclusion: Pediatric ED utilization and hospitalization during lockdown were decreased in the Netherlands and other countries, which can largely be attributed to a decrease in communicable infectious diseases. Care utilization for other conditions was decreased as well, which may indicate that care avoidance during a pandemic is significant. What is Known:• The COVID-19 pandemic had enormous impact on society.• Countries imposed lockdowns to curb transmission rates, which were followed by a reduction in care utilization worldwide. What is New:• The Dutch lockdown caused a significant decrease in pediatric ED utilization and hospitalization, especially in ED visits and hospital admissions because of infections that were not caused by SARS-CoV-2.• Care utilization for noninfectious diagnoses was decreased as well, which may indicate that pediatric care avoidance during a pandemic is significant.

22 April 2010 in Blood
Verified
Journal Article
Closed access
PDF file
MAMichael H. Albert
Michael H. Albert
TBTanja C. Bittner
Tanja C. Bittner
SNShigeaki Nonoyama
Shigeaki Nonoyama
LNLucia Dora Notarangelo
Lucia Dora Notarangelo
SBSiobhan Burns
Siobhan Burns
HOHans D. Ochs
Hans D. Ochs
A large proportion of patients with mutations in the Wiskott-Aldrich syndrome (WAS) protein gene exhibit the milder phenotype termed X-linked thrombocytopenia (XLT). Whereas stem cell transplantation at an early age is the treatment of choice for patients with WAS, therapeutic options for patients with XLT are controversial. In a retrospective multicenter study we defined the clinical phenotype of XLT and determined the probability of severe disease-related complications in patients older than 2 years with documented WAS gene mutations and mild-to-moderate eczema or mild, infrequent infections. Enrolled were 173 patients (median age, 11.5 years) from 12 countries spanning 2830 patient-years. Serious bleeding episodes occurred in 13.9%, life-threatening infections in 6.9%, autoimmunity in 12.1%, and malignancy in 5.2% of patients. Overall and event-free survival probabilities were not significantly influenced by the type of mutation or intravenous immunoglobulin or antibiotic prophylaxis. Splenectomy resulted in increased risk of severe infections. This analysis of the clinical outcome and molecular basis of patients with XLT shows excellent long-term survival but also a high probability of severe disease-related complications. These observations will allow better decision making when considering treatment options for individual patients with XLT.

24 October 2001 in European Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
KAKees Aleman
Kees Aleman
JNJeroen G. Noordzij
Jeroen G. Noordzij
RGRonald de Groot
Ronald de Groot
JDJacques J.M. van Dongen
Jacques J.M. van Dongen
NHNico G. Hartwig
Nico G. Hartwig

24 October 2002 in Blood
Verified
Journal Article
Closed access
PDF file
JNJeroen G. Noordzij
Jeroen G. Noordzij
NVNicole S. Verkaik
Nicole S. Verkaik
MBMirjam van der Burg
Mirjam van der Burg
LVLieneke R. van Veelen
Lieneke R. van Veelen
SBSandra de Bruin-Versteeg
Sandra de Bruin-Versteeg
JDJacques J.M. van Dongen
Jacques J.M. van Dongen
Severe combined immunodeficiency disease (SCID) can be immunologically classified by the absence or presence of T, B, and natural killer (NK) cells. About 30% of T−B−NK+ SCID patients carry mutations in the recombination activating genes (RAG). Some T−B−NK+ SCID patients withoutRAG gene mutations are sensitive to ionizing radiation, and several of these radiosensitive (RS) SCID patients were recently shown to have large deletions or truncation mutations in theArtemis gene, implying a role for Artemis in DNA double-strand break (dsb) repair. We identified 5 RS-SCID patients without RAG gene mutations, 4 of them withArtemis gene mutations. One patient had a large genomic deletion, but the other 3 patients carried simple missense mutations in conserved amino acid residues in the SNM1 homology domain of the Artemis protein. Extrachromosomal V(D)J recombination assays showed normal and precise signal joint formation, but inefficient coding joint formation in fibroblasts of these patients, which could be complemented by the wild-type Artemis gene. The cells containing the missense mutations in the SNM1 homology domain had the same recombination phenotype as the cells with the large deletion, indicating that these amino acid residues are indispensable for Artemis function. Immunogenotyping and immunophenotyping of bone marrow samples of 2 RS-SCID patients showed the absence of complete VH-JH gene rearrangements and consequently a complete B-cell differentiation arrest at the pre–B-cell receptor checkpoint—that is, at the transition from CyIgμ−pre-B-I cells to CyIgμ+ pre-B-II cells. The completeness of this arrest illustrates the importance of Artemis at this stage of lymphoid differentiation.

1 February 2002 in Pediatric Research
Verified
Journal Article
Closed access
JNJeroen G Noordzij
Jeroen G Noordzij
SBSandra De Bruin-Versteeg
Sandra De Bruin-Versteeg
WCW Marieke Comans-Bitter
W Marieke Comans-Bitter
NHNico G Hartwig
Nico G Hartwig
RHRudolf W Hendriks
Rudolf W Hendriks
JDJacques J.M. van Dongen
Jacques J.M. van Dongen